An investigation for investors in Eastman Chemical Company (NYSE:EMN) shares was announced and NYSE: EMN stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWire) -- 04/07/2021 --Certain directors of Eastman Chemical Company are under investigation over potential breaches of fiduciary duties.

Investors who purchased shares of Eastman Chemical Company (NYSE: EMN) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Eastman Chemical officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.

Eastman Chemical Company reported that its annual Total Revenue rose from over $9.27 billion in 2019 to over $8.47 billion in 2020, and that its Net Income declined from $759 million in 2019 to $478 million in 2020.

Shares of Eastman Chemical Company (NYSE: EMN) closed on April 6, 2021, at $111.57 per share.

Those who purchased shares of Eastman Chemical Company (NYSE: EMN), have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.